These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 17311817)

  • 1. Diagnosis, staging and prognostic factors.
    Schouten HC
    Ann Oncol; 2007 Jan; 18 Suppl 1():i22-i28. PubMed ID: 17311817
    [No Abstract]   [Full Text] [Related]  

  • 2. 7q22 deletion in myeloid malignancies: be attentive to the design of the FISH probe.
    Struski S; Luquet I
    Ann Biol Clin (Paris); 2019 Apr; 77(2):229-230. PubMed ID: 30907375
    [No Abstract]   [Full Text] [Related]  

  • 3. Comprehensive bone marrow diagnosis on a single aspiration sample. Plastic sections and cell suspensions for enzyme and immunohisto- and cytochemistry.
    van de Sandt MM; Herman CJ; Lindeman J
    Pathol Annu; 1987; 22 Pt 1():67-82. PubMed ID: 3554122
    [No Abstract]   [Full Text] [Related]  

  • 4. Bone Marrow Immunohistochemistry and Flow Cytometry in the Diagnosis of Malignant Hematologic Diseases With Emphasis on Lymphomas: A Comparative Retrospective Study.
    Landry M; Bienz MN; Sawan B; Temmar R; Beauregard P; Chaunt F; Lavigne J; Knecht H
    Appl Immunohistochem Mol Morphol; 2020 Aug; 28(7):508-512. PubMed ID: 31290784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining the Boundary Between Myelodysplastic Syndromes and Myeloproliferative Neoplasms.
    Loghavi S; Wang SA
    Surg Pathol Clin; 2019 Sep; 12(3):651-669. PubMed ID: 31352979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dyserythropoiesis in the diagnosis of the myelodysplastic syndromes and other myeloid neoplasms: problem areas.
    Goasguen JE; Bennett JM; Bain BJ; Brunning R; Vallespi MT; Tomonaga M; Zini G; Renault A;
    Br J Haematol; 2018 Aug; 182(4):526-533. PubMed ID: 29917221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical and histological studies of fundus oculi changes in malignant hematologic diseases].
    Klatt A; Herrmann G; Klatt R
    Dtsch Gesundheitsw; 1971 May; 26(21):967-70. PubMed ID: 5117089
    [No Abstract]   [Full Text] [Related]  

  • 8. [Retrospection of hematopathologic research of the past 50 years in China].
    Chen HS; Du XX
    Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):553-5. PubMed ID: 16468303
    [No Abstract]   [Full Text] [Related]  

  • 9. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.
    Vardiman JW; Thiele J; Arber DA; Brunning RD; Borowitz MJ; Porwit A; Harris NL; Le Beau MM; Hellström-Lindberg E; Tefferi A; Bloomfield CD
    Blood; 2009 Jul; 114(5):937-51. PubMed ID: 19357394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Speaking a common language in MDS/MPNs.
    Steensma DP
    Blood; 2015 Mar; 125(12):1849-51. PubMed ID: 25792730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myelodysplastic syndrome/myeloproliferative neoplasm, unclassifiable; rare cause of granulocytic sarcoma: A diagnostic dilemma.
    Mandal PK; Kumar M; Bhattyacharyya M
    Indian J Pathol Microbiol; 2016; 59(1):133-4. PubMed ID: 26960664
    [No Abstract]   [Full Text] [Related]  

  • 13. Editorial: Advances in diagnosis of hematological disorders.
    Choudhry VP
    Indian J Pediatr; 2013 Sep; 80(9):754-5. PubMed ID: 23943572
    [No Abstract]   [Full Text] [Related]  

  • 14. The relationship between the myelodysplastic syndromes and the myeloproliferative disorders.
    Bain BJ
    Leuk Lymphoma; 1999 Aug; 34(5-6):443-9. PubMed ID: 10492067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Panmyelopathy and myeloproliferative syndrome].
    Jorke D; Bach G
    Z Gesamte Inn Med; 1986 Nov; 41(21):595-8. PubMed ID: 3469815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blastic plasmacytoid dendritic cell neoplasm presenting as leukemia without cutaneous lesion.
    Awasthi NP; Qayoom S; Dabadghao S
    J Cancer Res Ther; 2017; 13(6):1056-1058. PubMed ID: 29237977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of elderly patients with hematological neoplasms.
    Mora O; Zucca E
    Ann Oncol; 2007 Jan; 18 Suppl 1():i49-i53. PubMed ID: 17311823
    [No Abstract]   [Full Text] [Related]  

  • 18. [Optimising therapy in patients with haematological malignancies].
    Dumontet C
    Bull Cancer; 2008 Oct; 95(10):959-62. PubMed ID: 19004726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of del(20q) in patients with hematological malignancies.
    Brezinová J; Zemanová Z; Ransdorfová S; Sindelárová L; Sisková M; Neuwirtová R; Cermák J; Michalová K
    Cancer Genet Cytogenet; 2005 Jul; 160(2):188-92. PubMed ID: 15993278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-nucleotide polymorphism array (SNP-A) improves the identification of chromosomal abnormalities by metaphase cytogenetics in myelodysplastic syndrome.
    da Silva FB; Machado-Neto JA; Bertini VHLL; Velloso EDRP; Ratis CA; Calado RT; Simões BP; Rego EM; Traina F
    J Clin Pathol; 2017 May; 70(5):435-442. PubMed ID: 27836923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.